Condition
Gene Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Gene Therapy clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (3), Australia (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Gene Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| KLN-1010 gene therapy for relapsed or refractory multiple myeloma | Phase 1 | Duarte, California and 10 other locations | Recruiting | Jul 20, 2025 |
| Perceptual evaluation and rehabilitation program for congenital hearing loss | — | Shanghai | Recruiting | Jun 17, 2025 |
| Comparing growth and development in children with beta-thalassemia after gene therapy | — | Tianjin, Tianjin Municipality | Recruiting | Aug 14, 2023 |
| Gene therapy for hemophilia A in adults | — | Tianjin, Tianjin Municipality | Recruiting | Jan 28, 2021 |
| Gene therapy for X-linked severe combined immunodeficiency using targeted busulfan conditioning | Phase 1/2 | Los Angeles, California and 3 other locations | Recruiting | Oct 17, 2017 |
| Comprehensive database for studying stem cell transplants and cellular therapies | — | Minneapolis, Minnesota and 1 other locations | Recruiting | Jul 20, 2010 |
All recruiting trials (6)
-
KLN-1010 gene therapy for relapsed or refractory multiple myeloma
This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.
-
Perceptual evaluation and rehabilitation program for congenital hearing loss
This project will try a gamified, age‑adjusted software program to measure and train speech, music, and spatial hearing in people born with hearing loss who use hearing aids, cochlear implants, or gene therapy.
-
Comparing growth and development in children with beta-thalassemia after gene therapy
This study looks at how gene therapy affects the growth and development of children with beta-thalassemia compared to those getting regular treatments and healthy kids.
-
Gene therapy for hemophilia A in adults
This study is testing a new gene therapy to see if it can safely help adults with hemophilia A who have very low levels of a crucial clotting factor.
-
Gene therapy for X-linked severe combined immunodeficiency using targeted busulfan conditioning
This study is testing a new gene therapy for patients with X-linked severe combined immunodeficiency to see if it can help their immune system work better after a special treatment to prepare their bodies.
-
Comprehensive database for studying stem cell transplants and cellular therapies
This study is creating a database to gather information on stem cell transplants and treatments to help improve recovery for patients and donors and make these therapies more accessible to everyone.
Related topics
Quick answers
How many Gene Therapy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (3 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.